Cargando…
LY6/PLAUR domain containing 3 (LYPD3) maintains melanoma cell stemness and mediates an immunosuppressive microenvironment
BACKGROUND: Malignant melanoma is a highly heterogeneous skin cancer with the highest mortality rate among dermatological cancers. Catenins form functional networks in the nucleus to regulate gene expression and determine cell fate. Dysregulation of catenin expression correlates with the malignant c...
Autores principales: | Hu, Yi-dou, Wu, Ke, Liu, Yuan-jie, Zhang, Qian, Shen, Hui, Ji, Jin, Fang, Dong, Xi, Song-yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10623712/ https://www.ncbi.nlm.nih.gov/pubmed/37924160 http://dx.doi.org/10.1186/s13062-023-00424-3 |
Ejemplares similares
-
Phospholipase A2 inhibitor and LY6/PLAUR domain-containing protein PINLYP regulates type I interferon innate immunity
por: Liu, Zhongshun, et al.
Publicado: (2021) -
The PLAUR signaling promotes chronic pruritus
por: Chen, Weiwei, et al.
Publicado: (2022) -
Comprehensive analysis of the importance of PLAUR in the progression and immune microenvironment of renal clear cell carcinoma
por: Wang, Zhiwei, et al.
Publicado: (2022) -
LYPD3, a New Biomarker and Therapeutic Target for Acute Myelogenous Leukemia
por: Hu, Tingting, et al.
Publicado: (2022) -
PLAUR polymorphisms and lung function in UK smokers
por: Stewart, Ceri E, et al.
Publicado: (2009)